300970 華綠生物
按盤價 
42.580 +0.580 (+1.381%)
42.580 +0.580 (+1.381%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.499 | 7.048 | -3.130 | 1.985 | 5.325 |
| 總資產報酬率 ROA (%) | 4.382 | 4.619 | -2.150 | 1.481 | 4.058 |
| 投入資產回報率 ROIC (%) | 4.871 | 5.157 | -2.410 | 1.644 | 4.412 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.133 | 16.099 | 5.959 | 13.522 | 16.320 |
| 營業利潤率 (%) | 28.786 | 9.588 | -4.271 | 2.727 | 10.767 |
| 息稅前利潤/營業總收入 (%) | 27.841 | 9.897 | -3.521 | 2.661 | 9.376 |
| 淨利潤/營業總收入 (%) | 28.793 | 9.231 | -4.304 | 2.647 | 10.333 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.463 | 93.843 | 91.021 | 140.938 | 85.129 |
| 價值變動淨收益/利潤總額(%) | 0.000 | 0.000 | -0.196 | 1.390 | 5.254 |
| 營業外收支淨額/利潤總額(%) | 0.024 | -3.818 | 0.434 | -3.021 | -1.175 | 償債能力分析 |
| 流動比率 (X) | 4.135 | 3.404 | 2.606 | 2.686 | 3.837 |
| 速動比率 (X) | 3.127 | 2.486 | 1.725 | 1.881 | 2.987 |
| 資產負債率 (%) | 29.716 | 32.293 | 34.098 | 26.005 | 23.118 |
| 帶息債務/全部投入資本 (%) | 13.707 | 13.719 | 15.003 | 10.088 | 13.940 |
| 股東權益/帶息債務 (%) | 553.897 | 538.882 | 482.281 | 814.013 | 599.162 |
| 股東權益/負債合計 (%) | 230.633 | 205.281 | 189.795 | 280.865 | 329.901 |
| 利息保障倍數 (X) | -29.269 | 14.938 | -4.577 | 193.875 | -7.407 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 3.753 | 4.256 | 6.171 | 5.628 | 11.833 |
| 存貨周轉天數 (天) | 73.230 | 69.926 | 71.264 | 72.141 | 75.843 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
